Escrito por estudiantes que aprobaron Inmediatamente disponible después del pago Leer en línea o como PDF ¿Documento equivocado? Cámbialo gratis 4,6 TrustPilot
logo-home
Document preview thumbnail
Vista previa 1 fuera de 4 páginas
Examen

CEA Prep: Cardiac Questions And Answers Rated A+ New Update Assured Satisfaction

Document preview thumbnail
Vista previa 1 fuera de 4 páginas

What is the key long-term benefit of using carvedilol for patients with coronary artery disease and heart failure with reduced ejection fraction (HFrEF)? - CORRECT ANSWER-Potential increase in ejection fraction Rationale: EF increase is a key reason for using carvedilol over metoprolol for patients with low EF states. Libido unfortunately can be negatively impacted by any beta blocker. Cardiac output should only improve with long term use, not decrease, and beta blockers may reduce blood pressure slightly, but that is not their key long-term benefit. In fact, they are not even considered for routine anti-hypertensive management per JNC-8 guidelines. An example of secondary prevention for a diagnosis of coronary artery disease includes which of the following? - CORRECT ANSWER-Coronary artery bypass grafting Rationale: CABG represents the only guaranteed evidence of fixing patients who already have coronary artery disease. The rest remain as primary prevention strategies. Effective long-term treatment of systolic heart failure with reduced ejection fraction should include which of the following? - CORRECT ANSWER-Prescribing valsartan/sacubitril (Entresto) unless contraindicated on discharge Rationale: Angiotensin Receptor and Neprilysin Inhibition is considered goal-directed therapy for patients with reduced systolic heart function as evidence by the PARAGONHF Trial. Auscultation is an assessment item, not a treatment. Midazolam does not have any long term benefit for heart failure. Fluid bolus in a patient with likely fluid overload from systolic heart failure only worsen their presenting symptoms.

Vista previa del contenido

CEA Prep: Cardiac
What is the key long-term benefit of using carvedilol for patients with coronary artery
disease and heart failure with reduced ejection fraction (HFrEF)? - CORRECT
ANSWER-Potential increase in ejection fraction
Rationale: EF increase is a key reason for using carvedilol over metoprolol for patients
with low EF states. Libido unfortunately can be negatively impacted by any beta blocker.
Cardiac output should only improve with long term use, not decrease, and beta blockers
may reduce blood pressure slightly, but that is not their key long-term benefit. In fact,
they are not even considered for routine anti-hypertensive management per JNC-8
guidelines.

An example of secondary prevention for a diagnosis of coronary artery disease includes
which of the following? - CORRECT ANSWER-Coronary artery bypass grafting
Rationale: CABG represents the only guaranteed evidence of fixing patients who
already have coronary artery disease. The rest remain as primary prevention strategies.

Effective long-term treatment of systolic heart failure with reduced ejection fraction
should include which of the following? - CORRECT ANSWER-Prescribing
valsartan/sacubitril (Entresto) unless contraindicated on discharge
Rationale: Angiotensin Receptor and Neprilysin Inhibition is considered goal-directed
therapy for patients with reduced systolic heart function as evidence by the PARAGON-
HF Trial. Auscultation is an assessment item, not a treatment. Midazolam does not have
any long term benefit for heart failure. Fluid bolus in a patient with likely fluid overload
from systolic heart failure only worsen their presenting symptoms.

Which of the following end-organ sequelae is not directly caused by uncontrolled
hypertension? - CORRECT ANSWER-Peripheral neuropathy
Rationale: Although patients with hypertension frequently have peripheral neuropathy, it
is only directly attributed to patients who are also diabetic and is commonly found in
non-hypertensive diabetic patients. Proteinuria, AV nicking, and hemorrhagic stroke are
all caused by uncontrolled hypertension.


A 70-year-old man with a history of atrial fibrillation presents with sudden-onset left-
sided weakness and slurred speech. What is the most likely diagnosis? - CORRECT
ANSWER-Stroke
Rationale: The patient with a history of atrial fibrillation for over 48 hours without
anticoagulation is at risk of an embolic stroke, secondary to mobilization of a thrombus
(90% of which occur in the left atrial appendage). A patient exhibiting signs of a stroke
such as unilateral weakness and slurred speech, in addition to being evaluated for

Información del documento

Subido en
10 de mayo de 2025
Número de páginas
4
Escrito en
2024/2025
Tipo
Examen
Contiene
Preguntas y respuestas
$9.99

¿Documento equivocado? Cámbialo gratis Dentro de los 14 días posteriores a la compra y antes de descargarlo, puedes elegir otro documento. Puedes gastar el importe de nuevo.
Escrito por estudiantes que aprobaron
Inmediatamente disponible después del pago
Leer en línea o como PDF

Seller avatar
Los indicadores de reputación están sujetos a la cantidad de artículos vendidos por una tarifa y las reseñas que ha recibido por esos documentos. Hay tres niveles: Bronce, Plata y Oro. Cuanto mayor reputación, más podrás confiar en la calidad del trabajo del vendedor.
Brainarium
3.8
(333)
Vendido
1979
Seguidores
1046
Artículos
23853
Última venta
12 horas hace



Por qué los estudiantes eligen Stuvia

Creado por compañeros estudiantes, verificado por reseñas

Calidad en la que puedes confiar: escrito por estudiantes que aprobaron y evaluado por otros que han usado estos resúmenes.

¿No estás satisfecho? Elige otro documento

¡No te preocupes! Puedes elegir directamente otro documento que se ajuste mejor a lo que buscas.

Paga como quieras, empieza a estudiar al instante

Sin suscripción, sin compromisos. Paga como estés acostumbrado con tarjeta de crédito y descarga tu documento PDF inmediatamente.

Student with book image

“Comprado, descargado y aprobado. Así de fácil puede ser.”

Alisha Student

Preguntas frecuentes